Announcements Trials

Browse Landscape

Phase

Status

Completed 45 Unknown 16 Not yet recruiting 5 Terminated 4 Withdrawn 3 Recruiting 1 Enrolling by invitation 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Advanced Ovarian Cancer 1

Interventions

pembrolizumab 436 Carboplatin 321 Nivolumab 287 Cyclophosphamide 280 Specimen Handling 257 Cisplatin 251 Paclitaxel 248 Magnetic Resonance Spectroscopy 248 Radiotherapy 217 Gemcitabine 180 Dexamethasone 180 Biopsy 177 durvalumab 166 atezolizumab 148 Rituximab 138 Lenalidomide 134 Doxorubicin 134 Docetaxel 130 Bevacizumab 129 Ipilimumab 125 Radiation 118 Capecitabine 117 Pemetrexed 112 Oxaliplatin 112 Etoposide 111 Radiosurgery 108 Fluorouracil 108 venetoclax 106 fludarabine 106 Prednisone 97

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Interventional × Ropivacaine × Clear all

NCT04065009 2024-01-11

IPLA-OVCA

Karolinska Institutet

Phase 3 Active not recruiting

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡